Results of Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the ASCO Breast Cancer Symposium 2011
Results of Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the ASCO Breast Cancer Symposium 2011
August 24, 2011
Results of Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the ASCO Breast Cancer Symposium 2011 Oral presentation will take place Saturday, September 10, 2011